Header Logo

Connection

Julie Schneider to Amyloid beta-Peptides

Back to Details
This is a "connection" page, showing publications Julie Schneider has written about Amyloid beta-Peptides.
Julie Schneider
Connection Strength
5.255
Amyloid beta-Peptides
  1. Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia. JAMA Neurol. 2024 Mar 01; 81(3):233-239.
    View in: PubMed
    Score: 0.194
  2. High-throughput digital quantification of Alzheimer disease pathology and associated infrastructure in large autopsy studies. J Neuropathol Exp Neurol. 2023 Nov 20; 82(12):976-986.
    View in: PubMed
    Score: 0.190
  3. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 2023 07; 146(1):1-11.
    View in: PubMed
    Score: 0.182
  4. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023 05 30; 100(22):e2259-e2268.
    View in: PubMed
    Score: 0.181
  5. Neuropathology of the Common Forms of Dementia. Clin Geriatr Med. 2023 02; 39(1):91-107.
    View in: PubMed
    Score: 0.176
  6. Association of Traumatic Brain Injury With and Without Loss of Consciousness With Neuropathologic Outcomes in Community-Dwelling Older Persons. JAMA Netw Open. 2022 04 01; 5(4):e229311.
    View in: PubMed
    Score: 0.170
  7. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.167
  8. Off-label use of aducanumab for cerebral amyloid angiopathy. Lancet Neurol. 2021 08; 20(8):596-597.
    View in: PubMed
    Score: 0.161
  9. Association of Amyloid-? Pathology with Decision Making and Scam Susceptibility. J Alzheimers Dis. 2021; 83(2):879-887.
    View in: PubMed
    Score: 0.156
  10. Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns. J Neuropathol Exp Neurol. 2020 11 01; 79(11):1141-1146.
    View in: PubMed
    Score: 0.154
  11. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.145
  12. Association of Cortical ?-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. JAMA Neurol. 2019 07 01; 76(7):818-826.
    View in: PubMed
    Score: 0.140
  13. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A?, tau, immunity and lipid processing. Nat Genet. 2019 03; 51(3):414-430.
    View in: PubMed
    Score: 0.137
  14. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease. Acta Neuropathol. 2019 05; 137(5):801-823.
    View in: PubMed
    Score: 0.137
  15. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies. Neurobiol Aging. 2019 02; 74:171-181.
    View in: PubMed
    Score: 0.134
  16. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018 08 01; 75(8):989-998.
    View in: PubMed
    Score: 0.132
  17. Genetic epistasis regulates amyloid deposition in resilient aging. Alzheimers Dement. 2017 Oct; 13(10):1107-1116.
    View in: PubMed
    Score: 0.120
  18. The cerebral cortex in cerebral amyloid angiopathy. Lancet Neurol. 2016 07; 15(8):778-779.
    View in: PubMed
    Score: 0.114
  19. Association of APOE with tau-tangle pathology with and without ?-amyloid. Neurobiol Aging. 2016 Jan; 37:19-25.
    View in: PubMed
    Score: 0.108
  20. Central role for PICALM in amyloid-? blood-brain barrier transcytosis and clearance. Nat Neurosci. 2015 Jul; 18(7):978-87.
    View in: PubMed
    Score: 0.106
  21. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol. 2015 May; 129(5):757-62.
    View in: PubMed
    Score: 0.104
  22. Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy. Curr Alzheimer Res. 2014 May; 11(4):309-16.
    View in: PubMed
    Score: 0.098
  23. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.094
  24. Elevated A?42 in aged, non-demented individuals with cerebral atherosclerosis. Curr Alzheimer Res. 2013 Oct; 10(8):785-9.
    View in: PubMed
    Score: 0.094
  25. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-e4 carriers. PLoS Genet. 2013; 9(8):e1003685.
    View in: PubMed
    Score: 0.094
  26. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
    View in: PubMed
    Score: 0.092
  27. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013 Aug 15; 208(4):564-72.
    View in: PubMed
    Score: 0.092
  28. Brain amyloid-? oligomers in ageing and Alzheimer's disease. Brain. 2013 May; 136(Pt 5):1383-98.
    View in: PubMed
    Score: 0.091
  29. The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease. J Neurosci. 2012 Nov 21; 32(47):16857-71a.
    View in: PubMed
    Score: 0.089
  30. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012 Oct; 72(4):599-609.
    View in: PubMed
    Score: 0.088
  31. Correlation of amyloid PET ligand florbetapir F 18 binding with A? aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord. 2012 Jan-Mar; 26(1):8-16.
    View in: PubMed
    Score: 0.083
  32. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011 Jan 19; 305(3):275-83.
    View in: PubMed
    Score: 0.078
  33. Antemortem amyloid imaging and ?-amyloid pathology in a case with dementia with Lewy bodies. Neurobiol Aging. 2012 May; 33(5):878-85.
    View in: PubMed
    Score: 0.077
  34. Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. Nat Commun. 2023 Nov 30; 14(1):7659.
    View in: PubMed
    Score: 0.048
  35. Age-related and amyloid-beta-independent tau deposition and its downstream effects. Brain. 2023 08 01; 146(8):3192-3205.
    View in: PubMed
    Score: 0.047
  36. When Alzheimer's is LATE: Why Does it Matter? Ann Neurol. 2023 08; 94(2):211-222.
    View in: PubMed
    Score: 0.046
  37. Brain ?-Amyloid Links the Association of Change in Body Mass Index With Cognitive Decline in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2023 02 24; 78(2):277-285.
    View in: PubMed
    Score: 0.045
  38. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023 04 04; 100(14):e1474-e1487.
    View in: PubMed
    Score: 0.045
  39. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain. 2022 08 27; 145(8):2823-2833.
    View in: PubMed
    Score: 0.044
  40. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022 08; 21(8):714-725.
    View in: PubMed
    Score: 0.043
  41. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol. 2022 07; 144(1):59-79.
    View in: PubMed
    Score: 0.043
  42. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. J Neuropathol Exp Neurol. 2021 01 20; 80(2):102-111.
    View in: PubMed
    Score: 0.039
  43. A cortical immune network map identifies distinct microglial transcriptional programs associated with ?-amyloid and Tau pathologies. Transl Psychiatry. 2021 01 14; 11(1):50.
    View in: PubMed
    Score: 0.039
  44. Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology. Neuron. 2020 08 05; 107(3):496-508.e6.
    View in: PubMed
    Score: 0.037
  45. Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease. Neurobiol Aging. 2020 09; 93:61-68.
    View in: PubMed
    Score: 0.037
  46. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020 01; 26(1):131-142.
    View in: PubMed
    Score: 0.036
  47. Sex differences in the genetic predictors of Alzheimer's pathology. Brain. 2019 09 01; 142(9):2581-2589.
    View in: PubMed
    Score: 0.036
  48. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease. Mol Psychiatry. 2021 03; 26(3):888-896.
    View in: PubMed
    Score: 0.035
  49. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
    View in: PubMed
    Score: 0.034
  50. Vascular dysfunction-The disregarded partner of Alzheimer's disease. Alzheimers Dement. 2019 01; 15(1):158-167.
    View in: PubMed
    Score: 0.034
  51. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains. Nat Neurosci. 2019 01; 22(1):37-46.
    View in: PubMed
    Score: 0.034
  52. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol. 2018 07; 84(1):78-88.
    View in: PubMed
    Score: 0.033
  53. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.033
  54. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease. Nat Neurosci. 2018 06; 21(6):811-819.
    View in: PubMed
    Score: 0.033
  55. Genetic influence of plasma homocysteine on Alzheimer's disease. Neurobiol Aging. 2018 02; 62:243.e7-243.e14.
    View in: PubMed
    Score: 0.031
  56. Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging. 2018 01; 61:138-145.
    View in: PubMed
    Score: 0.031
  57. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. J Neurol Neurosurg Psychiatry. 2017 11; 88(11):982-994.
    View in: PubMed
    Score: 0.031
  58. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Mol Neurodegener. 2017 07 01; 12(1):51.
    View in: PubMed
    Score: 0.031
  59. Interaction of transactive response DNA binding protein 43 with nuclear factor ?B in mild cognitive impairment with episodic memory deficits. Acta Neuropathol Commun. 2014 Apr 01; 2:37.
    View in: PubMed
    Score: 0.024
  60. Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec; 70(12):1544-51.
    View in: PubMed
    Score: 0.024
  61. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
    View in: PubMed
    Score: 0.023
  62. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.022
  63. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012 May; 71(5):362-81.
    View in: PubMed
    Score: 0.021
  64. Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm (Vienna). 2009 May; 116(5):587-97.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.